Phio Pharmaceuticals Corp (NASDAQ:PHIO) traded at $2.11 at last check on current trade day and made a downward move of -15.94% on its previous day’s price.
Looking at the stock we see that its previous close was $2.51 and the beta (5Y monthly) reads 1.083 with the day’s price range being $2.015 – $2.4999. In terms of its 52-week price range, PHIO has a high of $9.79 and a low of $0.97. The company’s stock has gained about 62.31% over that past 30 days.
Phio Pharmaceuticals Corp has a market cap of $10.08 million and is expected to release its quarterly earnings report on 2025-Mar-30.
On the other hand, looking at the outlook for the PHIO stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is 22.82% off its SMA20 and 34.68% from its 50-day simple moving average. The RSI (14) is pointing at 56.83 while the volatility over the past week is 21.65% and jumps to 17.16% over the past one month. The beta value is 0.51, while the average true range (ATR) is currently pointing at 0.34.
Coming back to Phio Pharmaceuticals Corp (NASDAQ:PHIO), we note that the average 3-month trading volume was 3.17 million, while that of the preceding 10-day period stands at 17.28 million. Current shares outstanding are 4.78 million.
The insiders hold 11.45% of the company’s shares while institutions hold 5.13%. The data shows that short shares as of 2025-03-31, stood at 78709.0 at a short ratio of 0.77. This represents a 165.00 short interest in shares outstanding on 2025-03-31. Shares short rose in March from the previous month at 66736.0. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 17.22% up in year-to-date price movement.
